Listed

Standard Biotools Inc.

LABNasdaqCIK 1162194HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$20.1m, Q2 FY2026
Operating income−$25.4m, Q2 FY2026
Net income−$26.8m, Q2 FY2026
Standard Biotools Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q3 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m25.4Revenue, Q3 FY2023, three months to 2023-09-30$25.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure28.2Revenue, Q4 FY2023, three months to 2023-12-31$28.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure45.5Revenue, Q3 FY2024, three months to 2024-03-31$45.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure22.5Revenue, Q2 FY2024, three months to 2024-06-30$22.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure22.1Revenue, Q3 FY2024, three months to 2024-09-30$22.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure24.8Revenue, Q4 FY2024, three months to 2024-12-31$24.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure20.2Revenue, Q1 FY2025, three months to 2025-03-31$20.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure21.8Revenue, Q2 FY2025, three months to 2025-06-30$21.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure19.6Revenue, Q3 FY2025, three months to 2025-09-30$19.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure23.8Revenue, Q4 FY2025, three months to 2025-12-31$23.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure21.1Revenue, Q1 FY2026, three months to 2026-03-31$21.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure20.1Revenue, Q2 FY2026, three months to 2026-06-30$20.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Cost of revenue$m14.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$14.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure14.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure21.4Cost of revenue, Q3 FY2024, three months to 2024-03-31$21.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure12.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$12.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure10.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$10.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure13.4Cost of revenue, Q4 FY2024, three months to 2024-12-31$13.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure9.2Cost of revenue, Q1 FY2025, three months to 2025-03-31$9.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure11.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$11.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure10.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$10.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure12.4Cost of revenue, Q4 FY2025, three months to 2025-12-31$12.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure9.8Cost of revenue, Q1 FY2026, three months to 2026-03-31$9.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure9.6Cost of revenue, Q2 FY2026, three months to 2026-06-30$9.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Gross profit$m11.2Gross profit, Q3 FY2023, three months to 2023-09-30$11.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure13.4Gross profit, Q4 FY2023, three months to 2023-12-31$13.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure24.2Gross profit, Q3 FY2024, three months to 2024-03-31$24.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure10.4Gross profit, Q2 FY2024, three months to 2024-06-30$10.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure12.1Gross profit, Q3 FY2024, three months to 2024-09-30$12.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure11.4Gross profit, Q4 FY2024, three months to 2024-12-31$11.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure11.0Gross profit, Q1 FY2025, three months to 2025-03-31$11.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure10.6Gross profit, Q2 FY2025, three months to 2025-06-30$10.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure9.5Gross profit, Q3 FY2025, three months to 2025-09-30$9.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure11.4Gross profit, Q4 FY2025, three months to 2025-12-31$11.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure11.3Gross profit, Q1 FY2026, three months to 2026-03-31$11.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure10.5Gross profit, Q2 FY2026, three months to 2026-06-30$10.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Research and development$m6.4Research and development, Q3 FY2023, three months to 2023-09-30$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure6.9Research and development, Q4 FY2023, three months to 2023-12-31$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure16.0Research and development, Q3 FY2024, three months to 2024-03-31$16.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure7.2Research and development, Q2 FY2024, three months to 2024-06-30$7.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure6.9Research and development, Q3 FY2024, three months to 2024-09-30$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure7.0Research and development, Q4 FY2024, three months to 2024-12-31$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure5.4Research and development, Q1 FY2025, three months to 2025-03-31$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure6.2Research and development, Q2 FY2025, three months to 2025-06-30$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure6.4Research and development, Q3 FY2025, three months to 2025-09-30$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure8.0Research and development, Q4 FY2025, three months to 2025-12-31$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure2.1Research and development, Q1 FY2026, three months to 2026-03-31$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure2.0Research and development, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Selling, general and administrative$m22.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$22.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure21.4Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$21.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure46.9Selling, general and administrative, Q3 FY2024, three months to 2024-03-31$46.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure24.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$24.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure24.5Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$24.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure27.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$27.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure29.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$29.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure28.1Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$28.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure26.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$26.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure25.3Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$25.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure18.6Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$18.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure16.4Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$16.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Operating income$m(21.2)Operating income, Q3 FY2023, three months to 2023-09-30−$21.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure(21.4)Operating income, Q4 FY2023, three months to 2023-12-31−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(60.2)Operating income, Q3 FY2024, three months to 2024-03-31−$60.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure(30.3)Operating income, Q2 FY2024, three months to 2024-06-30−$30.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure(26.7)Operating income, Q3 FY2024, three months to 2024-09-30−$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure(26.1)Operating income, Q4 FY2024, three months to 2024-12-31−$26.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(27.0)Operating income, Q1 FY2025, three months to 2025-03-31−$27.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(25.7)Operating income, Q2 FY2025, three months to 2025-06-30−$25.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(32.9)Operating income, Q3 FY2025, three months to 2025-09-30−$32.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure(24.6)Operating income, Q4 FY2025, three months to 2025-12-31−$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Operating income, Q1 FY2026, three months to 2026-03-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(25.4)Operating income, Q2 FY2026, three months to 2026-06-30−$25.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Interest expense$m1.2Interest expense, Q3 FY2023, three months to 2023-09-30$1.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure1.1Interest expense, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-01, accession 0000950170-24-023845. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.1Income tax, Q3 FY2023, three months to 2023-09-30$50.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure(0.2)Income tax, Q4 FY2023, three months to 2023-12-31−$162.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-03-31$128.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$39.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$118.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure0.3Income tax, Q4 FY2024, three months to 2024-12-31$272.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(0.1)Income tax, Q1 FY2025, three months to 2025-03-31−$119.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(0.6)Income tax, Q2 FY2025, three months to 2025-06-30−$609.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(1.2)Income tax, Q3 FY2025, three months to 2025-09-30−$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure(35.9)Income tax, Q4 FY2025, three months to 2025-12-31−$35.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$11.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$90.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Net income$m(21.0)Net income, Q3 FY2023, three months to 2023-09-30−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure(19.8)Net income, Q4 FY2023, three months to 2023-12-31−$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(32.2)Net income, Q3 FY2024, three months to 2024-03-31−$32.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure(45.7)Net income, Q2 FY2024, three months to 2024-06-30−$45.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure(26.9)Net income, Q3 FY2024, three months to 2024-09-30−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure(34.1)Net income, Q4 FY2024, three months to 2024-12-31−$34.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(26.0)Net income, Q1 FY2025, three months to 2025-03-31−$26.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(33.5)Net income, Q2 FY2025, three months to 2025-06-30−$33.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(34.7)Net income, Q3 FY2025, three months to 2025-09-30−$34.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure19.3Net income, Q4 FY2025, three months to 2025-12-31$19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure127Net income, Q1 FY2026, three months to 2026-03-31$127.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(26.8)Net income, Q2 FY2026, three months to 2026-06-30−$26.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Diluted EPS$ per share(0.27)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figurenot reported(0.27)Diluted EPS, Q3 FY2024, three months to 2024-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure(0.12)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure(0.07)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(0.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(0.09)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figurenot reported0.33Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Basic EPS$ per share(0.27)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figurenot reported(0.27)Basic EPS, Q3 FY2024, three months to 2024-03-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure(0.12)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure(0.07)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figurenot reported(0.07)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure(0.09)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figurenot reported0.33Basic EPS, Q1 FY2026, three months to 2026-03-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(0.07)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure

Balance sheet

Cash and equivalents$270.0m, Q2 FY2026
Long-term debt$299.0k, FY2024
Shareholders' equity$540.0m, Q2 FY2026
Standard Biotools Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q3 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m79.7Cash and equivalents, Q3 FY2023, at 2023-09-30$79.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure51.7Cash and equivalents, FY2023, at 2023-12-31$51.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figure287Cash and equivalents, Q3 FY2024, at 2024-03-31$287.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure270Cash and equivalents, Q2 FY2024, at 2024-06-30$269.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure211Cash and equivalents, Q3 FY2024, at 2024-09-30$210.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure167Cash and equivalents, FY2024, at 2024-12-31$166.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001193125-26-108326.Report this figure151Cash and equivalents, Q1 FY2025, at 2025-03-31$150.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure159Cash and equivalents, Q2 FY2025, at 2025-06-30$158.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure129Cash and equivalents, Q3 FY2025, at 2025-09-30$129.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure121Cash and equivalents, FY2025, at 2025-12-31$120.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure266Cash and equivalents, Q1 FY2026, at 2026-03-31$265.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure270Cash and equivalents, Q2 FY2026, at 2026-06-30$270.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Current assets$m171Current assets, Q3 FY2023, at 2023-09-30$170.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure158Current assets, FY2023, at 2023-12-31$158.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figure548Current assets, Q3 FY2024, at 2024-03-31$547.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure480Current assets, Q2 FY2024, at 2024-06-30$480.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure454Current assets, Q3 FY2024, at 2024-09-30$453.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure376Current assets, FY2024, at 2024-12-31$375.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108326.Report this figure344Current assets, Q1 FY2025, at 2025-03-31$344.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure506Current assets, Q2 FY2025, at 2025-06-30$506.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure472Current assets, Q3 FY2025, at 2025-09-30$472.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure454Current assets, FY2025, at 2025-12-31$454.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure521Current assets, Q1 FY2026, at 2026-03-31$521.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure517Current assets, Q2 FY2026, at 2026-06-30$516.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Total assets$m339Total assets, Q3 FY2023, at 2023-09-30$339.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure323Total assets, FY2023, at 2023-12-31$323.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figure778Total assets, Q3 FY2024, at 2024-03-31$777.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure709Total assets, Q2 FY2024, at 2024-06-30$708.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure682Total assets, Q3 FY2024, at 2024-09-30$681.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure612Total assets, FY2024, at 2024-12-31$612.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001193125-26-108326.Report this figure580Total assets, Q1 FY2025, at 2025-03-31$579.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure557Total assets, Q2 FY2025, at 2025-06-30$557.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure540Total assets, Q3 FY2025, at 2025-09-30$539.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure568Total assets, FY2025, at 2025-12-31$567.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure639Total assets, Q1 FY2026, at 2026-03-31$639.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure627Total assets, Q2 FY2026, at 2026-06-30$627.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Current liabilities$m51.8Current liabilities, Q3 FY2023, at 2023-09-30$51.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure109Current liabilities, FY2023, at 2023-12-31$109.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figure122Current liabilities, Q3 FY2024, at 2024-03-31$121.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure124Current liabilities, Q2 FY2024, at 2024-06-30$123.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure121Current liabilities, Q3 FY2024, at 2024-09-30$120.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure65.9Current liabilities, FY2024, at 2024-12-31$65.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001193125-26-108326.Report this figure56.2Current liabilities, Q1 FY2025, at 2025-03-31$56.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure98.0Current liabilities, Q2 FY2025, at 2025-06-30$98.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure108Current liabilities, Q3 FY2025, at 2025-09-30$108.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure108Current liabilities, FY2025, at 2025-12-31$108.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure42.2Current liabilities, Q1 FY2026, at 2026-03-31$42.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure56.8Current liabilities, Q2 FY2026, at 2026-06-30$56.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Total liabilities$m160Total liabilities, Q3 FY2023, at 2023-09-30$159.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure160Total liabilities, FY2023, at 2023-12-31$159.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figure200Total liabilities, Q3 FY2024, at 2024-03-31$200.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure198Total liabilities, Q2 FY2024, at 2024-06-30$198.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure192Total liabilities, Q3 FY2024, at 2024-09-30$192.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure141Total liabilities, FY2024, at 2024-12-31$140.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001193125-26-108326.Report this figure125Total liabilities, Q1 FY2025, at 2025-03-31$125.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure132Total liabilities, Q2 FY2025, at 2025-06-30$132.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure140Total liabilities, Q3 FY2025, at 2025-09-30$140.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure143Total liabilities, FY2025, at 2025-12-31$143.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure78.0Total liabilities, Q1 FY2026, at 2026-03-31$78.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure87.2Total liabilities, Q2 FY2026, at 2026-06-30$87.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure
Long-term debt$m64.6Long-term debt, Q3 FY2023, at 2023-09-30$64.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure63.5Long-term debt, FY2023, at 2023-12-31$63.5m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figure55.0Long-term debt, Q3 FY2024, at 2024-03-31$55.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure55.1Long-term debt, Q2 FY2024, at 2024-06-30$55.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure55.2Long-term debt, Q3 FY2024, at 2024-09-30$55.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure0.3Long-term debt, FY2024, at 2024-12-31$299.0k. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-11, accession 0000950170-25-036608.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(132)Shareholders' equity, Q3 FY2023, at 2023-09-30−$131.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure(148)Shareholders' equity, FY2023, at 2023-12-31−$148.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001193125-26-108326.Report this figure577Shareholders' equity, Q3 FY2024, at 2024-03-31$577.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure510Shareholders' equity, Q2 FY2024, at 2024-06-30$510.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure489Shareholders' equity, Q3 FY2024, at 2024-09-30$489.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure472Shareholders' equity, FY2024, at 2024-12-31$471.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure455Shareholders' equity, Q1 FY2025, at 2025-03-31$454.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure425Shareholders' equity, Q2 FY2025, at 2025-06-30$424.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure400Shareholders' equity, Q3 FY2025, at 2025-09-30$399.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure424Shareholders' equity, FY2025, at 2025-12-31$424.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure561Shareholders' equity, Q1 FY2026, at 2026-03-31$561.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure540Shareholders' equity, Q2 FY2026, at 2026-06-30$540.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure

Cash flow

Operating cash flow−$10.3m, Q2 FY2026
Capital expenditure$344.0k, Q2 FY2026
Share repurchases$0, Q4 FY2025
Standard Biotools Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q3 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(11.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$11.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122473. Derived: 9-month figure less the 6-month figure.Report this figure(14.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(62.5)Operating cash flow, Q3 FY2024, three months to 2024-03-31−$62.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure(39.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$39.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-15, accession 0000950170-25-109388. Derived: 6-month figure less the 3-month figure.Report this figure(27.9)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$27.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264695. Derived: 9-month figure less the 6-month figure.Report this figure(14.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(30.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$30.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(20.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335103. Derived: 6-month figure less the 3-month figure.Report this figure(22.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264695. Derived: 9-month figure less the 6-month figure.Report this figure(1.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure(46.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$46.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure(10.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335103. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$905.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122473. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$78.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure0.8Capital expenditure, Q3 FY2024, three months to 2024-03-31$781.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure1.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-15, accession 0000950170-25-109388. Derived: 6-month figure less the 3-month figure.Report this figure2.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264695. Derived: 9-month figure less the 6-month figure.Report this figure3.4Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure5.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure1.9Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335103. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$886.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264695. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2025, three months to 2025-12-31$476.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$570.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure0.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$344.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001193125-26-335103. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.4Share repurchases, Q3 FY2023, three months to 2023-09-30$400.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure0.2Share repurchases, Q4 FY2023, three months to 2023-12-31$174.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure11.1Share repurchases, Q3 FY2024, three months to 2024-03-31$11.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure29.4Share repurchases, Q2 FY2024, three months to 2024-06-30$29.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-15, accession 0000950170-25-109388. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001193125-25-264695. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-15, accession 0000950170-25-109388. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001193125-25-264695. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-16, accession 0001193125-26-108326. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)390.88m, Q2 FY2026
Standard Biotools Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q3 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares78.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3078,897,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060385.Report this figure79.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3179,080,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-057213.Report this figure78.7Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3078,669,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091888.Report this figure79.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3079,152,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122473.Report this figure294Diluted shares (weighted), Q3 FY2024, three months to 2024-03-31294,125,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064606.Report this figure372Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30372,331,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-15, accession 0000950170-25-109388.Report this figure372Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30371,538,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure378Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31378,228,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure380Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30380,498,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure383Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30382,630,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264695.Report this figure388Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31388,202,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001193125-26-208967.Report this figure391Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30390,881,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure

Shares outstanding: 392.58mShares outstanding, period not labelled, at 2026-08-03392,578,808 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335103.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.